Valsartan drugs recall in Canada: potential cancer risk
In plain language
This recall involves valsartan drugs sold in Canada. They are being recalled because they contain an impurity called NDMA, which may increase the risk of cancer with long-term exposure. Continue taking your medication unless advised otherwise by a healthcare provider and discuss treatment options.
What to do
- Check if your valsartan medication is on the list of recalled products.
- Contact your healthcare provider as soon as possible to discuss treatment options if you have been using an affected product.
- Continue taking your valsartan medication unless your healthcare provider advises you to stop.
- Contact your healthcare provider if you have concerns about your health after taking recalled valsartan products.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Why this matters
Potential cancer risk
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
Potential cancer risk
What should consumers do?
Check if your valsartan medication is on the list of recalled products. Contact your healthcare provider as soon as possible to discuss treatment options if you have been using an affected product. Continue taking your valsartan medication unless your healthcare provider advises you to stop. Contact your healthcare provider if you have concerns about your health after taking recalled valsartan products.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Potential cancer risk
When was this product recalled?
This product was recalled on September 10, 2018.